Crizanlizumab (Anti-P-Selectin / CD62p)

目录号:A2374        

打印

Crizanlizumab (Anti-P-Selectin / CD62p)是一种人源化单克隆免疫球蛋白 G1 抗 P-选择素抗体,具有血管保护和抗血管闭塞特性。分子量:144.24 kD。

抗体信息

CAS号 1690318-25-2
分子量 144.24 kDa
配制 100 mM Pro-Ac, 20mM Arg, pH5.0
推荐同型对照 Human IgG2SA
来源 CHO
储存条件
(自收到货起)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
纯化 AKTA
除菌 0.2 μM filtered

Crizanlizumab (Anti-P-Selectin / CD62p)在文献中得到引用

Tumor-Associated Platelets Suppress T-Cell Function and Promote Immune Evasion in TNBC via the P-selectin/ P-selectin glycoprotein ligand-1 Pathway [ Cancer Research Communications, June 16, 2026, nan] PubMed: 42302185
Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway [ Cancer Research Communications, July 10, 2026, 1640-1655] PubMed: 42302185

禁止用于人体及治疗!